Abstract <p>We recently developed a time-correlated single photon counting (TCSPC) spectroscopy approach to investigate the activation mechanisms of the calcium pump SERCA (sarcoplasmic reticulum Ca<sup>2+</sup>-ATPase). Here, we apply this approach to characterize the effects of two chemically distinct SERCA inhibitors, thapsigargin (TG) and cyclopiazonic acid (CPA), and to determine how they differentially modulate SERCA conformational dynamics. Although TG and CPA appear to stabilize similar SERCA states in structural studies, TCSPC reveals fundamentally distinct mechanisms of inhibition. TG stabilizes an inactive conformation that prevents Ca<sup>2+</sup>- and ATP-dependent transitions, effectively trapping SERCA in a nonproductive ‘dead-end’ state. In contrast, CPA attenuates, rather than abolishes, Ca<sup>2+</sup>- and nucleotide-dependent structural transitions, producing graded, concentration-dependent effects that reduce the population of the closed, activation-associated state. Notably, CPA decreases apparent Ca<sup>2+</sup> affinity only in the presence of a non-hydrolyzable ATP analog, consistent with an ATP-dependent, allosteric mechanism that redistributes conformational populations rather than directly occluding Ca<sup>2+</sup> binding sites. These findings demonstrate that TCSPC resolves mechanistic differences between inhibitors that appear structurally similar and provide a framework for understanding how distinct allosteric ligands modulate SERCA function.</p> Graphical Abstract <p></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Fluorescence Lifetime Spectroscopy Reveals Distinct Allosteric Mechanisms of SERCA Inhibitors

  • Jaroslava Šeflová,
  • Carlos Cruz-Cortés,
  • Seth L. Robia,
  • L. Michel Espinoza-Fonseca

摘要

Abstract

We recently developed a time-correlated single photon counting (TCSPC) spectroscopy approach to investigate the activation mechanisms of the calcium pump SERCA (sarcoplasmic reticulum Ca2+-ATPase). Here, we apply this approach to characterize the effects of two chemically distinct SERCA inhibitors, thapsigargin (TG) and cyclopiazonic acid (CPA), and to determine how they differentially modulate SERCA conformational dynamics. Although TG and CPA appear to stabilize similar SERCA states in structural studies, TCSPC reveals fundamentally distinct mechanisms of inhibition. TG stabilizes an inactive conformation that prevents Ca2+- and ATP-dependent transitions, effectively trapping SERCA in a nonproductive ‘dead-end’ state. In contrast, CPA attenuates, rather than abolishes, Ca2+- and nucleotide-dependent structural transitions, producing graded, concentration-dependent effects that reduce the population of the closed, activation-associated state. Notably, CPA decreases apparent Ca2+ affinity only in the presence of a non-hydrolyzable ATP analog, consistent with an ATP-dependent, allosteric mechanism that redistributes conformational populations rather than directly occluding Ca2+ binding sites. These findings demonstrate that TCSPC resolves mechanistic differences between inhibitors that appear structurally similar and provide a framework for understanding how distinct allosteric ligands modulate SERCA function.

Graphical Abstract